Amvis Holdings, Inc.

7071.T
Medical Care Facilities
2026/08/21 Updated
Market Cap: $265.3M (¥42.2B)
Stock Price: $2.70 (¥430)
Exchange Rate: 1 USD = ¥158.98

Financial Summary

For the second quarter of the fiscal year ending September 2026, revenue was 25,600 million yen (up 7.5% year-over-year), EBITDA was 4,444 million yen (up 62.6% YoY), with steady revenue growth and significant EBITDA increase. Full-year forecasts also remain solid.

Importance:
Page Updated: May 14, 2026
IR Disclosure Date: May 14, 2026

Key Figures

  • Revenue: 25,600 million yen (up 7.5% YoY)
  • EBITDA: 4,444 million yen (up 62.6% YoY)
  • Operating Income: 2,804 million yen (down 25.1% YoY)

AI要約

Performance Overview

Ambis Holdings Inc. recorded revenue of 25,600 million yen (up 7.5% YoY) and EBITDA of 4,444 million yen (up 62.6% YoY) in the second quarter of the fiscal year ending September 2026, indicating steady revenue growth. Operating income was 2,804 million yen, a decrease of 25.1% YoY; however, the significant increase in EBITDA suggests improved profitability. The full-year outlook remains favorable, with continued growth expected.

Future Outlook

The full-year forecast projects revenue of 517,000 million yen and EBITDA of 71,000 million yen, representing 7.5% and 62.6% increases YoY respectively. The company aims to continue expanding sales and improving profitability through proactive business development, with particular focus on expanding healthcare support and medical institution support services to pursue long-term growth.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Ambis Holdings Inc.

Company overview · Stock price · Financial data · All IR

View company page →